0000000000933273

AUTHOR

M Vitale

showing 7 related works from this author

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study

2013

Background: Cancer survival is a key measure of the effectiveness of health-care systems. EUROCARE-the largest cooperative study of population-based cancer survival in Europe-has shown persistent differences between countries for cancer survival, although in general, cancer survival is improving. Major changes in cancer diagnosis, treatment, and rehabilitation occurred in the early 2000s. EUROCARE-5 assesses their effect on cancer survival in 29 European countries. Methods: In this retrospective observational study, we analysed data from 107 cancer registries for more than 10 million patients with cancer diagnosed up to 2007 and followed up to 2008. Uniform quality control procedures were a…

GerontologyAdultMaleTime FactorsAdolescentColorectal cancerPopulationSettore MED/42 - Igiene Generale E ApplicataIR-88481NOProstate cancerBreast cancerMETIS-300341NeoplasmsmedicineHumansLung cancereducationAdolescent; Adult; Age Factors; Aged; Europe; Female; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Time Factorsddc:613AgedRetrospective Studieseducation.field_of_studyRelative survivalbusiness.industryOncology cancer survival eurocareAge FactorsCancerRetrospective cohort studycancer survival ; age ; country ; Europe ; Eurocare 5Middle Agedmedicine.diseaseCancer survivalEuropeOncologyFemaleNeoplasms/mortalitybusinessDemography
researchProduct

Tomografia WAM integrata dell’area sud-tirrenica e siciliana.

2008

Tomografia
researchProduct

Risk assessment of selection for restistant PrP alleles on milk production in Valle del Belice

2006

PrPsheepSettore AGR/17 - Zootecnica Generale E Miglioramento Geneticoselectionmilk production
researchProduct

PRELIMINARY COMPARISON FOR GENES INVOLVED IN BIOFILMS IN COAGULASE-NEGATIVE STAPHYLOCOCCI (CONS) AND S. AUREUS STRAINS ISOLATED FROM MILK SAMPLES OF …

2013

Coagulase-negative staphylococci food safety biofilmSettore BIO/19 - Microbiologia Generale
researchProduct

Molecular characterization of biofilm-forming S.aureus field isolates and their treatment

2008

PIA S.aureusSettore BIO/19 - Microbiologia Generale
researchProduct

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately …

2017

Background The best treatment option for patients with type 2 diabetes in whom treatment with metformin alone fails to achieve adequate glycaemic control is debated. We aimed to compare the long-term effects of pioglitazone versus sulfonylureas, given in addition to metformin, on cardiovascular events in patients with type 2 diabetes. Methods TOSCA.IT was a multicentre, randomised, pragmatic clinical trial, in which patients aged 50–75 years with type 2 diabetes inadequately controlled with metformin monotherapy (2–3 g per day) were recruited from 57 diabetes clinics in Italy. Patients were randomly assigned (1:1), by permuted blocks randomisation (block size 10), stratified by site and…

MaleDiabetes and Metabolism ipoglycemic drugs cardiovascualr eventSettore MED/09 - Medicina Internaendocrine system diseasesIMPACTpioglitazone versus sulfonylureasEndocrinology Diabetes and MetabolismGLIMEPIRIDEDiabetes cardiovascular events metformin pioglitazone sulphonylureasType 2 diabetes030204 cardiovascular system & hematologyInternal Medicine; Endocrinology Diabetes and Metabolism; Endocrinologylaw.inventionSettore MED/13 - EndocrinologiaGlibenclamide0302 clinical medicineRandomized controlled triallawGLYCEMIC CONTROLGliclazideInternal medicinediabetes and metabolismRISKeducation.field_of_studydiabetesIncidenceInternal medicine; endocrinology diabetes and metabolism; endocrinologyMiddle AgedINSULINMetforminMetforminTreatment OutcomeEditorialsulphonylureasCardiovascular DiseasesCombinationDrug Therapy CombinationFemaleType 2medicine.drugmedicine.medical_specialtyPopulation030209 endocrinology & metabolismAged; Cardiovascular Diseases; Diabetes Mellitus Type 2; Drug Therapy Combination; Female; Humans; Hypoglycemic Agents; Incidence; Male; Metformin; Middle Aged; Pioglitazone; Sulfonylurea Compounds; Thiazolidinediones; Treatment OutcomeCardiovascular events03 medical and health sciencesendocrinologyGLUCOSE-LOWERING DRUGSDrug TherapyInternal medicineDiabetes MellitusmedicineHumansHypoglycemic AgentssulfonylureaseducationTOSCA.ITAgedPioglitazonebusiness.industryMORTALITYnutritional and metabolic diseasesInsulin resistancemedicine.diseaseSurgeryGlimepirideSulfonylurea CompoundsDiabetes Mellitus Type 2Diabetes Mellitus; Pioglitazone; Insulin resistanceThiazolidinedionesbusinessFOLLOW-UPPioglitazone
researchProduct

Regulation of the biosynthesis of the dalbavancin precursor A40926

2008

Regulation of the biosynthesis of antibiotic dalbavancinSettore BIO/19 - Microbiologia Generale
researchProduct